Skip to content
646 269 0773|alita@globalbioethics.org
facebooktwitterlinkedin
Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo Global Bioethics Initiative (GBI) Logo
  • Home
  • About
  • Staff
    • Founders
    • Board of Directors
    • Advisory Board
    • Visiting Scholars
    • Student Interns
    • Volunteers
  • Events
  • Resources
    • COVID-19
  • Internships
  • Contact
  • Donate
Previous Next
  • View Larger Image

Drug Prices: What Can Be Done?

In it’s latest opinion, Dr. Elisabeth Rosenthal, argues that everyday drugs like EpiPen, should be economically affordable to all.

After Mylan, the pharmaceutical company and owner of EpiPen, raised the drug’s price from $100 in 2008 to $600 this year, it received a series of critics and backlash. This resulted in Mylan offering patients co-payments on the drug, as well as giving out generic versions of the drug.

Nonetheless, as Dr. Rosenthal says, this is just a temporary “band-aid” to a much bigger issue: while patients might not suffer the newly spiked cost at the pharmacy counter, insurance companies -which pay most of the drugs’ real cost- will increase their premiums next year; making it much harder for patients and family to have access to a basic life-saving drug.

Dr. Caplan, renowned bioethicist, suggests that big pharma should be regulated, so that they won’t “call the shots” on prices to much-needed drugs; and Dr. Rosenthal suggests the same, and other solutions: a national body that sets price ceilings for essential medicines.

You can read the whole article here.

Other Posts

Around 30%’ of eligible NY medical workers refusing COVID-19 vaccine: officialMalvika2021-01-10T13:28:50+00:00
Study suggests Pfizer vaccine works against virus variantMalvika2021-01-10T13:19:53+00:00
Rich Countries Have ‘Bought Up’ COVID-19 Vaccine Supply, Art Caplan SaysMalvika2020-12-18T13:39:02+00:00
First shipments of Pfizer vaccine to be delivered December 15Malvika2020-12-03T16:15:19+00:00
By Admin@gbi|2020-04-09T23:45:50+00:00September 3rd, 2016|News-Articles|0 Comments

Share This Story, Choose Your Platform!

facebooktwitterlinkedinreddittumblrpinterestvkEmail

About the Author: Admin@gbi

Avatar

Related Posts

  • Around 30%’ of eligible NY medical workers refusing COVID-19 vaccine: official
    Around 30%’ of eligible NY medical workers refusing COVID-19 vaccine: official
    Gallery

    Around 30%’ of eligible NY medical workers refusing COVID-19 vaccine: official

  • Study suggests Pfizer vaccine works against virus variant
    Study suggests Pfizer vaccine works against virus variant
    Gallery

    Study suggests Pfizer vaccine works against virus variant

  • Rich Countries Have ‘Bought Up’ COVID-19 Vaccine Supply, Art Caplan Says
    Rich Countries Have ‘Bought Up’ COVID-19 Vaccine Supply, Art Caplan Says
    Gallery

    Rich Countries Have ‘Bought Up’ COVID-19 Vaccine Supply, Art Caplan Says

  • First shipments of Pfizer vaccine to be delivered December 15
    First shipments of Pfizer vaccine to be delivered December 15
    Gallery

    First shipments of Pfizer vaccine to be delivered December 15

  • Bioethicists worry the rich and powerful will get special access to experimental Covid treatments
    Bioethicists worry the rich and powerful will get special access to experimental Covid treatments
    Gallery

    Bioethicists worry the rich and powerful will get special access to experimental Covid treatments

Leave A Comment Cancel reply

Recent Tweets

Tweets by GBISummerSchool

Find us on Facebook

Copyright 2012 - 2020 Global Bioethics | All Rights Reserved | Powered by Global Innovation Consortium
facebooktwitterlinkedin
Toggle Sliding Bar Area